PREDICT kidney feasibility study
Research type
Research Study
Full title
A feasibility study of incorporating the PREDICT Kidney risk communication tool into clinical care for patients who have undergone surgery for newly diagnosed localised renal cell carcinoma
IRAS ID
343656
Contact name
Juliet Usher-Smith
Contact email
Sponsor organisation
Cambridge University Hospitals NHS Foundation Trust
Duration of Study in the UK
0 years, 8 months, 31 days
Research summary
Kidney cancer is diagnosed in more than 4000 people annually in the UK. If the cancer has not spread outside the kidney, most patients will have surgery to remove it. It is recommended that doctors should estimate the risk of kidney cancer coming back after surgery for each patient, to help them decide appropriate follow-up. We have developed a new online tool, PREDICT Kidney, to help clinicians with this. This study aims to test this tool with a small number of patients and clinicians.
We will invite adults from hospitals in England and Scotland who have had surgery for kidney cancer to take part in the study after they have had surgery and before their first follow-up consultation. Around 60 participants will be allocated into two groups. Those in the first group will have the standard current level of care. This is a face-to-face clinic appointment where they are informed of the estimated risk of the cancer returning (i.e. low, intermediate or high) and given a follow-up plan based on that risk. For those in the second group the clinicians will use the new tool to give participants an estimated percentage risk of the cancer returning alongside the corresponding estimated percentage risk of dying from other causes. The participants will also be given a printout of those estimated risks. We will ask to record some consultations in both groups and patients will then be given questionnaires before, immediately after and 3 months after their appointment. We will also speak to a sample of patients in the second group and healthcare professionals to seek feedback regarding the tool.
We will use the findings from this study to improve the tool and plan a larger study to test whether using it improves patients’ understanding of their risk of recurrence and planned follow-up.
REC name
East of England - Cambridge South Research Ethics Committee
REC reference
24/EE/0216
Date of REC Opinion
23 Oct 2024
REC opinion
Further Information Favourable Opinion